Ledger.Open graph →
SEC Form D · filed December 28, 2015

ProPhase Labs, Inc

Offering
$3.0M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DOYLESTOWN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

James V. Mccubbin · Doylestown, PADirectorMark V. Burnett · Doylestown, PADirectorMark V. Leventhal · Doylestown, PADirectorTed Karkus · Doylestown, PAExec · DirectorLouis V. Gleckel · Doylestown, PADirectorLouis V. Gleckel · Doylestown, PADirectorRobert V. Cuddihy, Jr · Doylestown, PAExecJason V. Barr · Doylestown, PADirectorRobert V. Cuddihy, Jr · Doylestown, PAExecJames V. Mccubbin · Doylestown, PADirectorMark V. Burnett · Doylestown, PADirectorJason V. Barr · Doylestown, PADirectorMark V. Leventhal · Doylestown, PADirectorTed Karkus · Doylestown, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗